EMEA (Europe, Middle East and Africa) Allergy Immunotherapies Market Report 2017

December 2017 | 108 pages | ID: E6172938C6CEN
QYResearch

Abstracts

In this report, the EMEA Allergy Immunotherapies market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (Units), revenue (Million USD), market share and growth rate of Allergy Immunotherapies for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Allergy Immunotherapies market competition by top manufacturers/players, with Allergy Immunotherapies sales volume (Units), price (K USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• ALK Abello
• Allergy Therapeutics
• Circassia
• DBV Technologies
• Stallergenes Greer
• Merck KGaA (Allergopharma)
• HAL Allergy Group (Netherlands)

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Subcutaneous Immunotherapy
• Sublingual Immunotherapy

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Allergic Rhinitis
• Allergic Asthma
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Allergy Immunotherapies Market Report 2017

1 ALLERGY IMMUNOTHERAPIES OVERVIEW

1.1 Product Overview and Scope of Allergy Immunotherapies
1.2 Classification of Allergy Immunotherapies
  1.2.1 EMEA Allergy Immunotherapies Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Allergy Immunotherapies Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Subcutaneous Immunotherapy
  1.2.4 Sublingual Immunotherapy
1.3 EMEA Allergy Immunotherapies Market by Application/End Users
  1.3.1 EMEA Allergy Immunotherapies Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Allergic Rhinitis
  1.3.3 Allergic Asthma
  1.3.4 Other
1.4 EMEA Allergy Immunotherapies Market by Region
  1.4.1 EMEA Allergy Immunotherapies Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Allergy Immunotherapies (2012-2022)
  1.5.1 EMEA Allergy Immunotherapies Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Allergy Immunotherapies Revenue and Growth Rate (2012-2022)

2 EMEA ALLERGY IMMUNOTHERAPIES COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Allergy Immunotherapies Market Competition by Players/Manufacturers
  2.1.1 EMEA Allergy Immunotherapies Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Allergy Immunotherapies Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Allergy Immunotherapies Sale Price by Players (2012-2017)
2.2 EMEA Allergy Immunotherapies (Volume and Value) by Type/Product Category
  2.2.1 EMEA Allergy Immunotherapies Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Allergy Immunotherapies Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Allergy Immunotherapies Sale Price by Type (2012-2017)
2.3 EMEA Allergy Immunotherapies (Volume) by Application
2.4 EMEA Allergy Immunotherapies (Volume and Value) by Region
  2.4.1 EMEA Allergy Immunotherapies Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Allergy Immunotherapies Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Allergy Immunotherapies Sales Price by Region (2012-2017)

3 EUROPE ALLERGY IMMUNOTHERAPIES (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Allergy Immunotherapies Sales and Value (2012-2017)
  3.1.1 Europe Allergy Immunotherapies Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Allergy Immunotherapies Revenue and Growth Rate (2012-2017)
3.2 Europe Allergy Immunotherapies Sales and Market Share by Type
3.3 Europe Allergy Immunotherapies Sales and Market Share by Application
3.4 Europe Allergy Immunotherapies Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Allergy Immunotherapies Sales Volume by Countries (2012-2017)
  3.4.2 Europe Allergy Immunotherapies Revenue by Countries (2012-2017)
  3.4.3 Germany Allergy Immunotherapies Sales and Growth Rate (2012-2017)
  3.4.4 France Allergy Immunotherapies Sales and Growth Rate (2012-2017)
  3.4.5 UK Allergy Immunotherapies Sales and Growth Rate (2012-2017)
  3.4.6 Russia Allergy Immunotherapies Sales and Growth Rate (2012-2017)
  3.4.7 Italy Allergy Immunotherapies Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Allergy Immunotherapies Sales and Growth Rate (2012-2017)

4 MIDDLE EAST ALLERGY IMMUNOTHERAPIES (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Allergy Immunotherapies Sales and Value (2012-2017)
  4.1.1 Middle East Allergy Immunotherapies Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Allergy Immunotherapies Revenue and Growth Rate (2012-2017)
4.2 Middle East Allergy Immunotherapies Sales and Market Share by Type
4.3 Middle East Allergy Immunotherapies Sales and Market Share by Application
4.4 Middle East Allergy Immunotherapies Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Allergy Immunotherapies Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Allergy Immunotherapies Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Allergy Immunotherapies Sales and Growth Rate (2012-2017)
  4.4.4 Israel Allergy Immunotherapies Sales and Growth Rate (2012-2017)
  4.4.5 UAE Allergy Immunotherapies Sales and Growth Rate (2012-2017)
  4.4.6 Iran Allergy Immunotherapies Sales and Growth Rate (2012-2017)

5 AFRICA ALLERGY IMMUNOTHERAPIES (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Allergy Immunotherapies Sales and Value (2012-2017)
  5.1.1 Africa Allergy Immunotherapies Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Allergy Immunotherapies Revenue and Growth Rate (2012-2017)
5.2 Africa Allergy Immunotherapies Sales and Market Share by Type
5.3 Africa Allergy Immunotherapies Sales and Market Share by Application
5.4 Africa Allergy Immunotherapies Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Allergy Immunotherapies Sales Volume by Countries (2012-2017)
  5.4.2 Africa Allergy Immunotherapies Revenue by Countries (2012-2017)
  5.4.3 South Africa Allergy Immunotherapies Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Allergy Immunotherapies Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Allergy Immunotherapies Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Allergy Immunotherapies Sales and Growth Rate (2012-2017)

6 EMEA ALLERGY IMMUNOTHERAPIES MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 ALK Abello
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Allergy Immunotherapies Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 ALK Abello Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Allergy Therapeutics
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Allergy Immunotherapies Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Allergy Therapeutics Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Circassia
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Allergy Immunotherapies Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Circassia Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 DBV Technologies
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Allergy Immunotherapies Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 DBV Technologies Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Stallergenes Greer
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Allergy Immunotherapies Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Stallergenes Greer Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Merck KGaA (Allergopharma)
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Allergy Immunotherapies Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Merck KGaA (Allergopharma) Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 HAL Allergy Group (Netherlands)
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Allergy Immunotherapies Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 HAL Allergy Group (Netherlands) Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview

7 ALLERGY IMMUNOTHERAPIES MANUFACTURING COST ANALYSIS

7.1 Allergy Immunotherapies Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Allergy Immunotherapies

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Allergy Immunotherapies Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Allergy Immunotherapies Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA ALLERGY IMMUNOTHERAPIES MARKET FORECAST (2017-2022)

11.1 EMEA Allergy Immunotherapies Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Allergy Immunotherapies Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Allergy Immunotherapies Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Allergy Immunotherapies Price and Trend Forecast (2017-2022)
11.2 EMEA Allergy Immunotherapies Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Allergy Immunotherapies Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Allergy Immunotherapies Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Allergy Immunotherapies Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Allergy Immunotherapies Sales Forecast by Type (2017-2022)
11.7 EMEA Allergy Immunotherapies Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Allergy Immunotherapies
Figure EMEA Allergy Immunotherapies Sales Volume (Units) by Type (2012-2022)
Figure EMEA Allergy Immunotherapies Sales Volume Market Share by Type (Product Category) in 2016
Figure Subcutaneous Immunotherapy Product Picture
Figure Sublingual Immunotherapy Product Picture
Figure EMEA Allergy Immunotherapies Sales Volume (Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Allergy Immunotherapies by Application in 2016
Figure Allergic Rhinitis Examples
Table Key Downstream Customer in Allergic Rhinitis
Figure Allergic Asthma Examples
Table Key Downstream Customer in Allergic Asthma
Figure Other Examples
Table Key Downstream Customer in Other
Figure EMEA Allergy Immunotherapies Market Size (Million USD) by Region (2012-2022)
Figure Europe Allergy Immunotherapies Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Allergy Immunotherapies Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Allergy Immunotherapies Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Allergy Immunotherapies Revenue (Million USD) Status and Forecast by Countries
Figure Africa Allergy Immunotherapies Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Allergy Immunotherapies Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Allergy Immunotherapies Sales Volume and Growth Rate (2012-2022)
Figure EMEA Allergy Immunotherapies Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Allergy Immunotherapies Market Major Players Product Sales Volume (Units) (2012-2017)
Table EMEA Allergy Immunotherapies Sales Volume (Units) of Major Players (2012-2017)
Table EMEA Allergy Immunotherapies Sales Share by Players (2012-2017)
Figure 2016 Allergy Immunotherapies Sales Share by Players
Figure 2017 Allergy Immunotherapies Sales Share by Players
Figure EMEA Allergy Immunotherapies Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Allergy Immunotherapies Revenue (Million USD) by Players (2012-2017)
Table EMEA Allergy Immunotherapies Revenue Share by Players (2012-2017)
Table 2016 EMEA Allergy Immunotherapies Revenue Share by Players
Table 2017 EMEA Allergy Immunotherapies Revenue Share by Players
Table EMEA Allergy Immunotherapies Sale Price (K USD/Unit) by Players (2012-2017)
Table EMEA Allergy Immunotherapies Sales (Units) and Market Share by Type (2012-2017)
Table EMEA Allergy Immunotherapies Sales Share by Type (2012-2017)
Figure Sales Market Share of Allergy Immunotherapies by Type (2012-2017)
Figure EMEA Allergy Immunotherapies Sales Market Share by Type (2012-2017)
Table EMEA Allergy Immunotherapies Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Allergy Immunotherapies Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Allergy Immunotherapies by Type in 2016
Table EMEA Allergy Immunotherapies Sale Price (K USD/Unit) by Type (2012-2017)
Table EMEA Allergy Immunotherapies Sales (Units) and Market Share by Application (2012-2017)
Table EMEA Allergy Immunotherapies Sales Share by Application (2012-2017)
Figure Sales Market Share of Allergy Immunotherapies by Application (2012-2017)
Figure EMEA Allergy Immunotherapies Sales Market Share by Application in 2016
Table EMEA Allergy Immunotherapies Sales (Units) and Market Share by Region (2012-2017)
Table EMEA Allergy Immunotherapies Sales Share by Region (2012-2017)
Figure Sales Market Share of Allergy Immunotherapies by Region (2012-2017)
Figure EMEA Allergy Immunotherapies Sales Market Share in 2016
Table EMEA Allergy Immunotherapies Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Allergy Immunotherapies Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Allergy Immunotherapies by Region (2012-2017)
Figure EMEA Allergy Immunotherapies Revenue Market Share Regions in 2016
Table EMEA Allergy Immunotherapies Sales Price (K USD/Unit) by Region (2012-2017)
Figure Europe Allergy Immunotherapies Sales (Units) and Growth Rate (2012-2017)
Figure Europe Allergy Immunotherapies Revenue and Growth Rate (2012-2017)
Table Europe Allergy Immunotherapies Sales (Units) by Type (2012-2017)
Table Europe Allergy Immunotherapies Market Share by Type (2012-2017)
Figure Europe Allergy Immunotherapies Market Share by Type in 2016
Table Europe Allergy Immunotherapies Sales (Units) by Application (2012-2017)
Table Europe Allergy Immunotherapies Market Share by Application (2012-2017)
Figure Europe Allergy Immunotherapies Market Share by Application in 2016
Table Europe Allergy Immunotherapies Sales (Units) by Countries (2012-2017)
Table Europe Allergy Immunotherapies Sales Market Share by Countries (2012-2017)
Figure Europe Allergy Immunotherapies Sales Market Share by Countries (2012-2017)
Figure Europe Allergy Immunotherapies Sales Market Share by Countries in 2016
Table Europe Allergy Immunotherapies Revenue (Million USD) by Countries (2012-2017)
Table Europe Allergy Immunotherapies Revenue Market Share by Countries (2012-2017)
Figure Europe Allergy Immunotherapies Revenue Market Share by Countries (2012-2017)
Figure Europe Allergy Immunotherapies Revenue Market Share by Countries in 2016
Figure Germany Allergy Immunotherapies Sales (Units) and Growth Rate (2012-2017)
Figure France Allergy Immunotherapies Sales (Units) and Growth Rate (2012-2017)
Figure UK Allergy Immunotherapies Sales (Units) and Growth Rate (2012-2017)
Figure Russia Allergy Immunotherapies Sales (Units) and Growth Rate (2012-2017)
Figure Italy Allergy Immunotherapies Sales (Units) and Growth Rate (2012-2017)
Figure Benelux Allergy Immunotherapies Sales (Units) and Growth Rate (2012-2017)
Figure Middle East Allergy Immunotherapies Sales (Units) and Growth Rate (2012-2017)
Figure Middle East Allergy Immunotherapies Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Allergy Immunotherapies Sales (Units) by Type (2012-2017)
Table Middle East Allergy Immunotherapies Market Share by Type (2012-2017)
Figure Middle East Allergy Immunotherapies Market Share by Type (2012-2017)
Table Middle East Allergy Immunotherapies Sales (Units) by Applications (2012-2017)
Table Middle East Allergy Immunotherapies Market Share by Applications (2012-2017)
Figure Middle East Allergy Immunotherapies Sales Market Share by Application in 2016
Table Middle East Allergy Immunotherapies Sales Volume (Units) by Countries (2012-2017)
Table Middle East Allergy Immunotherapies Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Allergy Immunotherapies Sales Volume Market Share by Countries in 2016
Table Middle East Allergy Immunotherapies Revenue (Million USD) by Countries (2012-2017)
Table Middle East Allergy Immunotherapies Revenue Market Share by Countries (2012-2017)
Figure Middle East Allergy Immunotherapies Revenue Market Share by Countries (2012-2017)
Figure Middle East Allergy Immunotherapies Revenue Market Share by Countries in 2016
Figure Saudi Arabia Allergy Immunotherapies Sales (Units) and Growth Rate (2012-2017)
Figure Israel Allergy Immunotherapies Sales (Units) and Growth Rate (2012-2017)
Figure UAE Allergy Immunotherapies Sales (Units) and Growth Rate (2012-2017)
Figure Iran Allergy Immunotherapies Sales (Units) and Growth Rate (2012-2017)
Figure Africa Allergy Immunotherapies Sales (Units) and Growth Rate (2012-2017)
Figure Africa Allergy Immunotherapies Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Allergy Immunotherapies Sales (Units) by Type (2012-2017)
Table Africa Allergy Immunotherapies Sales Market Share by Type (2012-2017)
Figure Africa Allergy Immunotherapies Sales Market Share by Type (2012-2017)
Figure Africa Allergy Immunotherapies Sales Market Share by Type in 2016
Table Africa Allergy Immunotherapies Sales (Units) by Application (2012-2017)
Table Africa Allergy Immunotherapies Sales Market Share by Application (2012-2017)
Figure Africa Allergy Immunotherapies Sales Market Share by Application (2012-2017)
Table Africa Allergy Immunotherapies Sales Volume (Units) by Countries (2012-2017)
Table Africa Allergy Immunotherapies Sales Market Share by Countries (2012-2017)
Figure Africa Allergy Immunotherapies Sales Market Share by Countries (2012-2017)
Figure Africa Allergy Immunotherapies Sales Market Share by Countries in 2016
Table Africa Allergy Immunotherapies Revenue (Million USD) by Countries (2012-2017)
Table Africa Allergy Immunotherapies Revenue Market Share by Countries (2012-2017)
Figure Africa Allergy Immunotherapies Revenue Market Share by Countries (2012-2017)
Figure Africa Allergy Immunotherapies Revenue Market Share by Countries in 2016
Figure South Africa Allergy Immunotherapies Sales (Units) and Growth Rate (2012-2017)
Figure Nigeria Allergy Immunotherapies Sales (Units) and Growth Rate (2012-2017)
Figure Egypt Allergy Immunotherapies Sales (Units) and Growth Rate (2012-2017)
Figure Algeria Allergy Immunotherapies Sales (Units) and Growth Rate (2012-2017)
Table ALK Abello Allergy Immunotherapies Basic Information List
Table ALK Abello Allergy Immunotherapies Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure ALK Abello Allergy Immunotherapies Sales (Units) and Growth Rate (2012-2017)
Figure ALK Abello Allergy Immunotherapies Sales Market Share in EMEA (2012-2017)
Figure ALK Abello Allergy Immunotherapies Revenue Market Share in EMEA (2012-2017)
Table Allergy Therapeutics Allergy Immunotherapies Basic Information List
Table Allergy Therapeutics Allergy Immunotherapies Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Allergy Therapeutics Allergy Immunotherapies Sales (Units) and Growth Rate (2012-2017)
Figure Allergy Therapeutics Allergy Immunotherapies Sales Market Share in EMEA (2012-2017)
Figure Allergy Therapeutics Allergy Immunotherapies Revenue Market Share in EMEA (2012-2017)
Table Circassia Allergy Immunotherapies Basic Information List
Table Circassia Allergy Immunotherapies Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Circassia Allergy Immunotherapies Sales (Units) and Growth Rate (2012-2017)
Figure Circassia Allergy Immunotherapies Sales Market Share in EMEA (2012-2017)
Figure Circassia Allergy Immunotherapies Revenue Market Share in EMEA (2012-2017)
Table DBV Technologies Allergy Immunotherapies Basic Information List
Table DBV Technologies Allergy Immunotherapies Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure DBV Technologies Allergy Immunotherapies Sales (Units) and Growth Rate (2012-2017)
Figure DBV Technologies Allergy Immunotherapies Sales Market Share in EMEA (2012-2017)
Figure DBV Technologies Allergy Immunotherapies Revenue Market Share in EMEA (2012-2017)
Table Stallergenes Greer Allergy Immunotherapies Basic Information List
Table Stallergenes Greer Allergy Immunotherapies Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Stallergenes Greer Allergy Immunotherapies Sales (Units) and Growth Rate (2012-2017)
Figure Stallergenes Greer Allergy Immunotherapies Sales Market Share in EMEA (2012-2017)
Figure Stallergenes Greer Allergy Immunotherapies Revenue Market Share in EMEA (2012-2017)
Table Merck KGaA (Allergopharma) Allergy Immunotherapies Basic Information List
Table Merck KGaA (Allergopharma) Allergy Immunotherapies Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Merck KGaA (Allergopharma) Allergy Immunotherapies Sales (Units) and Growth Rate (2012-2017)
Figure Merck KGaA (Allergopharma) Allergy Immunotherapies Sales Market Share in EMEA (2012-2017)
Figure Merck KGaA (Allergopharma) Allergy Immunotherapies Revenue Market Share in EMEA (2012-2017)
Table HAL Allergy Group (Netherlands) Allergy Immunotherapies Basic Information List
Table HAL Allergy Group (Netherlands) Allergy Immunotherapies Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure HAL Allergy Group (Netherlands) Allergy Immunotherapies Sales (Units) and Growth Rate (2012-2017)
Figure HAL Allergy Group (Netherlands) Allergy Immunotherapies Sales Market Share in EMEA (2012-2017)
Figure HAL Allergy Group (Netherlands) Allergy Immunotherapies Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Allergy Immunotherapies
Figure Manufacturing Process Analysis of Allergy Immunotherapies
Figure Allergy Immunotherapies Industrial Chain Analysis
Table Raw Materials Sources of Allergy Immunotherapies Major Manufacturers in 2016
Table Major Buyers of Allergy Immunotherapies
Table Distributors/Traders List
Figure EMEA Allergy Immunotherapies Sales (Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Allergy Immunotherapies Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Allergy Immunotherapies Price (K USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Allergy Immunotherapies Sales (Units) Forecast by Region (2017-2022)
Figure EMEA Allergy Immunotherapies Sales Market Share Forecast by Region (2017-2022)
Table EMEA Allergy Immunotherapies Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Allergy Immunotherapies Revenue Market Share Forecast by Region (2017-2022)
Table Europe Allergy Immunotherapies Sales (Units) Forecast by Countries (2017-2022)
Figure Europe Allergy Immunotherapies Sales Market Share Forecast by Countries (2017-2022)
Table Europe Allergy Immunotherapies Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Allergy Immunotherapies Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Allergy Immunotherapies Sales (Units) Forecast by Countries (2017-2022)
Figure Middle East Allergy Immunotherapies Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Allergy Immunotherapies Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Allergy Immunotherapies Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Allergy Immunotherapies Sales (Units) Forecast by Countries (2017-2022)
Figure Africa Allergy Immunotherapies Sales Market Share Forecast by Countries (2017-2022)
Table Africa Allergy Immunotherapies Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Allergy Immunotherapies Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Allergy Immunotherapies Sales (Units) Forecast by Type (2017-2022)
Figure EMEA Allergy Immunotherapies Sales Market Share Forecast by Type (2017-2022)
Table EMEA Allergy Immunotherapies Sales (Units) Forecast by Application (2017-2022)
Figure EMEA Allergy Immunotherapies Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources